Donor-replicated, medication-stratified, radiometrically verified factorial experiments must demonstrate non-cytotoxic net matrix remodeling before a clinical adjunct is justified.
Such protocols have the theoretical potential to reduce thermal injury and postoperative re-adhesion risks, though prospective clinical verification is still required.
While both repeated piezocision and LLLT accelerate upper canine retraction during the initial three months without harming periodontal health, piezocision seems to be more effective than LLLT in speed and time reduction.
This review proposes the principle that patient selection should precede protocol selection because PBM acts on biologically responsive targets, not on diagnostic labels alone.
Most trials carried a high or unclear risk of bias, and treatment protocols were heterogeneous. Larger trials with standardized dosimetry are needed to establish the clinical value of PBM therapy at the palatal donor site.
Review · November 7, 2026 · Chu Thi Quynh H et al.
Photobiomodulation combined with the Rocabado approach is more effective than the Rocabado approach alone in improving pain intensity, pain threshold, maximum mouth opening, and TMJ function in patients with myogenic TMDs.
LLLT did not reduce OIIRR or shorten leveling and alignment duration but significantly attenuated short-term pain, supporting its use as a nonpharmacological analgesic adjunct in orthodontics.
Despite mechanistic promise, evidence supports only 3 biophotonic applications for clinical use: photobiomodulation for the prevention of oral mucositis, photodynamic therapy for oral leukoplakia, and fluorescence-based caries detection; other indications remain investigational.
The integrated protocol is biologically plausible but hypothesis generating. Prior distributions are derived from selective narrative evidence and carry acknowledged, formally quantified uncertainty, addressed through mandatory pre-specified sensitivity analyses.
We address critical gaps in current literature-including reporting shortfalls, negative clinical trials, and general safety risks-and outline the technological evolution toward target-tissue dosimetry.
Over 48 weeks, PBM + SM and OS + SM produced comparable improvements in pain and maximum painless mouth opening, with no significant between-group difference in masticatory muscle tender points at week 48.
The combined use of aPDT and PBMT with the described laser parameters seemed to be a promising, conservative and effective approach to optimize root canal disinfection, promoting local analgesy and possible accelerating apical bone remodeling.
PBM exerts a fluence-dependent effect on human PDLSCs. A single irradiation at 2 J/cm2 increased proliferation, whereas the irradiation regimen initiated at 2 J/cm2 promoted osteoblastogenesis.